Kansas HB2218 amends the definition of "psilocybin" to exclude its pharmaceutical composition and adds crystalline polymorph psilocybin to Schedule.

Kansas HB2218 modifies the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin, known as COMP 360. The bill also adds crystalline polymorph psilocybin to Schedule IV of the controlled substances act. This change ensures that only the pharmaceutical composition of crystalline polymorph psilocybin is excluded from the definition of psilocybin, while other forms remain regulated. The bill further amends and repeals sections of K.S.A. 2024 Supp. 65-4101 and 65-4111 to reflect these changes.

Kansas HB2218 amends the definition of "psilocybin" to exclude its pharmaceutical composition and adds crystalline polymorph psilocybin to Schedule.

Kansas HB2218 modifies the definition of "psilocybin" in the uniform controlled substances act to exclude the pharmaceutical composition of crystalline polymorph psilocybin, known as COMP 360. The bill also adds crystalline polymorph psilocybin to Schedule IV of the controlled substances act. This change ensures that only the pharmaceutical composition of crystalline polymorph psilocybin is excluded from the definition of psilocybin, while other forms remain regulated. The bill further amends and repeals sections of K.S.A. 2024 Supp. 65-4101 and 65-4111 to reflect these changes.